News
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) and the Open Applications Group, Inc. (OAGi) are proud to announce the release of a groundbreaking set of ontologies designed to enhance data interoperability and analytics capabilities across the biopharmaceutical industry. These ontologies are the result of a...
Today, NIIMBL (the National Institute for Innovation in Manufacturing Biopharmaceuticals) announced that a NIIMBL-led team will receive $10.5 Million in funding through the Gates Grand Challenges Program to advance exceptionally low-cost monoclonal antibody (mAb) manufacturing. Over the three-year award, key partners including Sartorius...
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) is pleased to announce awards for two projects to support Big Data Program initiatives on modeling and simulation. The awards stem from two Requests for Applications (RFAs) NIIMBL released in May 2025.
The 12-month projects are scheduled to begin in December.
The...